A part of Watch Media

MedWatchSaturday4 February 2023

  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
04/07/2022at 15:12

Fertin Pharma's bottom line suffers as bonuses and postponed product launches bite

The top-line results are unchanged for Fertin Pharma, but the bottom line has taken a hit. Delayed product launches and a bonus paid to all employees have made their mark on the books.
Photo: Fertin Pharma / PR
by christian bundgaard, translated by catherine brett

Fertin Pharma has had an eventful 2021.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters

Get full access for you and your coworkers

Start a free company trial today

Related articles:

  • Chief Medical Officer at Biontech, Özlem Türeci, believes that companies will soon be measured on how useful they are to society, not how profitable they are. | Photo: Biontech/PR

    Biontech wants to save the world by developing drugs without clear commercial potential

    For subscribers

  • Photo: Virginia Mayo/AP/Ritzau Scanpix

    Drug sales outweighed pandemic impact on Janssen Denmark's 2021 report

    For subscribers

  • Lena Lachenmeier, CEO of Qufora | Photo: Qufora / PR

    Qufora lifts long-term goals despite supply challenges

    For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Nu mangler kun en endelig vedtagelse i EU-Parlamentet, før lovforslag om at udskyde deadlines for nye krav til medicinsk udstyr. er en realitet. | Foto: Thomas Borberg/Ritzau Scanpix
Medtech

Another hurdle overcome in delaying MDR deadline

EU member countries have voted unanimously to adopt an EU Commission proposal to stagger the implementation of the new Medical Device Regulation. Now, only the EU Parliament’s vote remains. 
  • Asensus Surgical wins CE Mark for intelligent surgical unit under MDR rules
  • EU Commission to give more time for MDR transition

For subscribers

Foto: Stine Tidsvilde
Pharma & biotech

Novo Nordisk hopes to retain employees with share gift

For subscribers

Foto: MedWatch
Other

Top news from MedWatch this week

Luja can potentially solve a long-lived UTI problem for people who need help with bladder control issues by using new micro-hole technology
Medtech

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

For subscribers

Foto: Coloplast/pr
Medtech

Coloplast launches male catheter featuring new technology

For subscribers

Foto: Coloplast / Pr
Medtech

Coloplast's bottom line disappoints in otherwise strong report

For subscribers

Further reading

Foto: Alk / Pr
Pharma & biotech

ALK forecasts lower growth in 2023 than strong 2022 result

The allergy firm thinks 7–11% growth in 2023 is likely after a strong 2022 performance meets an upgraded guidance from the summer.

For subscribers

Foto: Coloplast / Pr
Medtech

Analyst: China headwinds will dampen Coloplast's first quarter

Covid-19 shutdowns in China have restricted patients’ hospital access, which Danish bank Sydbank says will hurt revenue inflows for the Danish medtech company.

For subscribers

Foto: Gn Hearing / Pr
Hearing health

GN's high expectations deadlocking stock price

Despite shorting positions declining the past month, the hearing company’s equity hasn’t moved an inch in 2023 – perhaps due to conflicting expectations for a yet-to-be-revealed fourth-quarter report.

For subscribers

Latest news

  • Top news from MedWatch this week – 3 Feb
  • Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps – 3 Feb
  • China accepts regulatory filing for ALK allergy tablet – 3 Feb
  • Another hurdle overcome in delaying MDR deadline – 3 Feb
  • Dupixent becomes ninefold blockbuster – 3 Feb
  • ALK forecasts lower growth in 2023 than strong 2022 result – 3 Feb
  • Unilabs and Siemens Healthineers enter million-euro strategic partnership – 3 Feb
  • Coloplast launches male catheter featuring new technology – 3 Feb
  • Novo Nordisk hopes to retain employees with share gift – 3 Feb
  • Coloplast's bottom line disappoints in otherwise strong report – 3 Feb
See all

Jobs

  • Clinical Operational Associate

  • Senior Clinical Project Manager

  • Application Manager

  • Sr. Director, Drug Safety Physician

  • Commercial Director

  • Application Manager

  • Supply Chain Manager

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Regulatory Affairs Professional

  • Lead Data Architect

  • Medical Advisor (Metabolism)

  • Senior Health Economics and Outcomes Research (HEOR) Manager

  • Experienced Patent Counsel

See all jobs

Jobs

  • Clinical Operational Associate

  • Senior Clinical Project Manager

  • Application Manager

  • Sr. Director, Drug Safety Physician

  • Commercial Director

  • Application Manager

  • Supply Chain Manager

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Regulatory Affairs Professional

  • Lead Data Architect

  • Medical Advisor (Metabolism)

  • Senior Health Economics and Outcomes Research (HEOR) Manager

  • Experienced Patent Counsel

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved

Microsoft is in the process of discontinuing Internet Explorer – and so are we.
For a better experience, we recommend using one of the following browsers.

Kind regards,
MedWatch

Google ChromeMozilla FirefoxMicrosoft Edge